Common Stock, Shares, Outstanding of LISATA THERAPEUTICS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
LISATA THERAPEUTICS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • LISATA THERAPEUTICS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 8,833,875, a 5.1% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

LISATA THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 8,833,875 +425,031 +5.1% 31 Dec 2025 10-K 12 Mar 2026 2024 FY
Q3 2025 8,755,948 +436,348 +5.2% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 8,626,464 +305,403 +3.7% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 8,620,162 +312,729 +3.8% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 8,408,844 +258,947 +3.2% 31 Dec 2024 10-K 12 Mar 2026 2024 FY
Q3 2024 8,319,600 +180,151 +2.2% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 8,321,061 +188,704 +2.3% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 8,307,433 +309,091 +3.9% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 8,149,897 +283,836 +3.6% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 8,139,449 +276,847 +3.5% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 8,132,357 -52,450,892 -87% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 7,998,342 -52,534,722 -87% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 7,866,061 +3,880,080 +97% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 7,862,602 -51,917,253 -87% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 60,583,249 +1,065,791 +1.8% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 60,533,064 +1,034,106 +1.7% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 3,985,981 -15,392,352 -79% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 59,779,855 +40,372,798 +208% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 59,517,458 +43,932,264 +282% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 59,498,958 +48,860,187 +459% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 19,378,333 +8,860,724 +84% 31 Dec 2020 10-K 22 Mar 2022 2021 FY
Q3 2020 19,407,057 +8,996,047 +86% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 15,585,194 +5,172,444 +50% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 10,638,771 +245,459 +2.4% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 10,517,609 +651,874 +6.6% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 10,411,010 +557,947 +5.7% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 10,412,750 +677,389 +7% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 10,393,312 +818,627 +8.6% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 9,865,735 +381,824 +4% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 9,853,063 +426,062 +4.5% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 9,735,361 +822,759 +9.2% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 9,574,685 +621,373 +6.9% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 9,483,911 +1,278,121 +16% 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q3 2017 9,427,001 +1,245,080 +15% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 8,912,602 +2,985,853 +50% 30 Jun 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 8,953,312 -50,169,948 -85% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 8,205,790 +2,532,488 +45% 31 Dec 2016 10-K 22 Mar 2018 2017 FY
Q3 2016 8,181,921 -47,315,319 -85% 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 5,926,749 -49,526,265 -89% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 59,123,260 +19,699,349 +50% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 5,673,302 -31,110,555 -85% 31 Dec 2015 10-Q 07 Nov 2016 2016 Q3
Q3 2015 55,497,240 +20,011,717 +56% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 55,453,014 +20,513,791 +59% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 39,423,911 +10,830,501 +38% 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 36,783,857 +9,587,320 +35% 31 Dec 2014 10-Q 05 Nov 2015 2015 Q3
Q3 2014 35,485,523 +14,291,653 +67% 30 Sep 2014 10-Q 30 Oct 2014 2014 Q3
Q2 2014 34,939,223 +15,354,848 +78% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 28,593,410 -141,685,321 -83% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 27,196,537 +10,821,172 +66% 31 Dec 2013 10-Q 30 Oct 2014 2014 Q3
Q3 2013 21,193,870 -133,947,216 -86% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 19,584,375 -118,035,528 -86% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 170,278,731 +40,391,583 +31% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 16,375,365 -92,954,222 -85% 31 Dec 2012 10-K 13 Mar 2014 2013 FY
Q3 2012 155,141,086 +54,779,643 +55% 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 137,619,903 +55,372,616 +67% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 129,887,148 31 Mar 2012 10-Q 11 May 2012 2012 Q1
Q4 2011 109,329,587 +45,108,457 +70% 31 Dec 2011 10-K 11 Mar 2013 2012 FY
Q3 2011 100,361,443 30 Sep 2011 10-Q 10 Nov 2011 2011 Q3
Q2 2011 82,247,287 30 Jun 2011 10-Q 12 Aug 2011 2011 Q2
Q4 2010 64,221,130 31 Dec 2010 8-K 15 Aug 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.